Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Adicet Bio shares promising look at CAR-T for lupus, but stock drops anyway

Adicet Bio reported that its off-the-shelf CAR-T therapy improved symptoms for lupus patients in an early-stage study, and it plans to soon start a pivotal trial. The Bay Area company in ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Monday 28 September →